13D Filing: Versant Venture Capital IV, L.P. and Crispr Therapeutics AG (CRSP)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of...

Keep Reading →